Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 28 Jun, 09:53 pm
Macquarie downgraded Trip.com Group Limited to Neutral with a $44.30 price target, signaling a cautious outlook for the online travel agency . Despite missing earnings per share estimates at $0.83 , the company reported robust revenue growth of 17% year-over-year, reaching $2.40
Winnebago Industries reported a significant earnings and revenue miss, falling short of analyst expectations. The company has revised its outlook downwards due to declining sales in the recreational vehicle (RV) market. Despite recent performance challenges, Winnebago Industries
Jefferies raises the price target for Applied Materials to $770.00 , citing new chipmaking systems for AI . The company benefits from strong AI-driven demand , showing robust growth forecasts and projected sales and EPS growth . Applied Materials' stock has rallied over 140% year
Intensifying Competition: Nike faces significant challenges from emerging brands like On Holding and Hoka, particularly in the running shoe market, prompting a strategic turnaround effort. Analyst Downgrade: KeyBanc downgraded Nike's stock to "Sector Weight" on June 26, 2026, ref
America's Car-Mart is anticipated to report a negative EPS of -$0.66 and $334.88 million in revenue, reflecting analyst concerns. The company exhibits recent unprofitability, marked by a negative Price-to-Earnings (P/E) ratio of -0.33 and a negative earnings yield of -3.00 . Faci
ProQR Therapeutics (NASDAQ:PRQR) Sees Price Target Cut Despite Positive Clinical Data and New Funding ProQR Therapeutics (NASDAQ:PRQR) is a clinical-stage biotechnology company focused on RNA editing technology to correct genetic mutations. Despite a lowered price target by Chard
Analyst firm Jefferies has raised its price target for IHG, signaling a positive outlook and potential upside for the stock. InterContinental Hotels Group is actively engaging in share buybacks, a strategic move designed to enhance shareholder value by reducing outstanding shares
Bio-Techne (NASDAQ:TECH) is the target of a major acquisition offer from Merck KGaA for $73 per share, valuing the company at approximately $11.3 billion . Analyst firm William Blair downgraded Bio-Techne's stock to "Market Perform," reflecting limited upside potential given the
BlackBerry (NYSE: BB) reported robust first-quarter results, surpassing analyst expectations for both earnings per share and revenue. The company demonstrated significant financial momentum with 26% growth in first-quarter sales and a 144% increase in adjusted EBITDA. Positive fi
Analyst Upgrade: Cowen & Co. upgraded Diageo's stock rating from Hold to Buy, signaling potential for growth in the alcoholic beverage sector . Promotional Strategy: Diageo is increasing promotional activity for its US spirits brands to stabilize sales amidst lower consumer deman
Individual companies such as IceCure Medical Ltd. , and ARS Pharmaceuticals, Inc. experienced significant stock drops, often influenced by specific company news or lack of positive catalysts. Exchange-Traded Funds (ETFs) , including the Defiance Daily Target 2X Short MU ETF and D
The stock market posted solid gains today, led by strong company earnings and continued momentum across the technology and artificial intelligence sectors. Several stocks and sector-linked funds delivered notable advances, reflecting investor optimism around better-than-expected
Analyst Optimism & Price Target: Jefferies sets a $575.00 price target for Lockheed Martin, indicating a 13.87% potential upside from its current trading price of $504.95 . Major Defense Contract Wins: Lockheed Martin secured $43.50 billion in new defense contracts, including sig
AeroVironment (NASDAQ: AVAV) is set to report its Q4 earnings on June 29, 2026, after market close, operating within a growing aerospace and defense sector. Analysts anticipate revenue of $557.17 million and earnings per share of $1.47 . The company demonstrates strong financial
Citigroup lowered its price target for Trip.com (NASDAQ: TCOM) to $64 from $82 , yet maintained a "Buy" rating, indicating continued investment potential. Trip.com's Q1 earnings per share (EPS) of $0.83 missed analyst estimates, but its revenue surged 17% to $2.35 billion , surpa
Nayax (NASDAQ: NYAX) is expanding its fintech solutions into the electric vehicle (EV) charging market through a strategic partnership with Tellus Power. Key financial metrics , including a high price-to-earnings (P/E) ratio of 84.81 , a debt-to-equity ratio of 1.42 , and a curre
Merck KGaA is set to acquire Bio-Techne Corporation (NASDAQ:TECH) in an all-cash transaction at $73.00 per share. The acquisition price represents a 24% premium, leading to a 19.80% surge in Bio-Techne Corporation shares. An investor rights law firm is investigating the deal to e
Commercial Metals Company (NYSE: CMC) exceeded Q3 EPS estimates, reporting $1.73 per share against a $1.60 consensus. The steel manufacturer achieved strong Q3 revenue of $2.48 billion , surpassing estimates and marking a 22.90% year-over-year increase. Consolidated core EBITDA s
Headlines provided by Investing.com